Provided by Tiger Trade Technology Pte. Ltd.

Attovia Therapeutics

20.31
-0.4900-2.36%
Volume:57.80K
Turnover:1.18M
Market Cap:873.92M
PE:-13.63
High:20.93
Open:20.80
Low:19.74
Close:20.80
52wk High:24.32
52wk Low:16.15
Shares:43.03M
Float Shares:17.00M
Volume Ratio:0.19
T/O Rate:0.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4900
EPS(LYR):-15.3508
ROE:--
ROA:--
PB:-6.96
PE(LYR):-1.32

Loading ...

Goldman Sachs Reports Sale of 105,807 Attovia Therapeutics Shares Worth $2.22 Million

Reuters
·
Aug 14

Major Investor Makes Bold Move Into Attovia Therapeutics

TIPRANKS
·
Aug 11

venBio Global Strategic Fund IV Reports Attovia Therapeutics Common Share Acquisition Valued at $6.5 Million

Reuters
·
Aug 11

Major Investor Doubles Down on Attovia Therapeutics in Bold New Move

TIPRANKS
·
Aug 07

Attovia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire
·
Aug 07

Biotech Firm Attovia Therapeutics Surges Nearly 29% in Nasdaq Debut

Stock News
·
Aug 06

Stock Track | Attovia Therapeutics Soars 23.53% in Nasdaq Debut After Upsized $289 Million IPO

Stock Track
·
Aug 06

Attovia indicated to open at $20, IPO priced at $17

TIPRANKS
·
Aug 05

Attovia indicated to open at $24, IPO priced at $17

TIPRANKS
·
Aug 05

Attovia Therapeutics Poised to Surge in NASDAQ Debut After Upsized $289 Million IPO

Reuters
·
Aug 05

Attovia Therapeutics Prices Upsized IPO at $17 Per Share

Reuters
·
Aug 05

Attovia Therapeutics Announces Pricing of Upsized Initial Public Offering

THOMSON REUTERS
·
Aug 05

Attovia Therapeutics to Sell 17 Million Shares at $17 Each in IPO

Dow Jones
·
Aug 04

Goldman Sachs-Backed Attovia Eyes $731.5 Million Valuation in Upsized US IPO

Reuters
·
Aug 04

Attovia Therapeutics - Estimated IPO Price Set at $17 Per Share - SEC Filing

THOMSON REUTERS
·
Aug 04

Goldman Sachs-Backed Immunotherapy Pioneer Attovia (ATTO.US) Heads to Nasdaq: Targeting $212.5 Million in Top Funding, Adding Fuel to Biotech IPO Boom

Stock News
·
Jul 30